Can J Gastroenterol Hepatol. 2024;2024:5667986.
The Predictive Value of Time-Varying Noninvasive Scores on Long-Term Prognosis of NAFLD in South Korea.
제1저자 정성원 · 교신저자 김윤준
소속 (5)
- Department of Internal Medicine and Liver Research Institute Seoul National University College of Medicine, Seoul, Republic of Korea.
- Department of Gastroenterology Liver Center Asan Medical Center University of Ulsan College of Medicine, Seoul, Republic of Korea.
- Department of Internal Medicine Seoul National University Bundang Hospital Seoul National University College of Medicine, Seoul, Republic of Korea.
- Merck & Co., Inc., Rahway, NJ, USA.
- Department of Internal Medicine Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul, Republic of Korea.
Abstract
BACKGROUND This study aimed to examine whether repeated measurements on noninvasive fibrosis scores during follow-up improve long-term nonalcoholic fatty liver disease (NAFLD) outcome prediction.
METHODS A cohort study of 2,280 NAFLD patients diagnosed at the Seoul National University Hospital from 2001 to 2015 was conducted. Multivariable Cox regression models with baseline and designated time-point measurements of the fibrosis-4 index (FIB-4) and NAFLD fibrosis score (NFS) were used to assess the association between these scores and overall mortality, liver-related outcomes, and cardiovascular events.
RESULTS Higher baseline NFS (high versus low probability for advanced fibrosis groups) was associated with higher risk of mortality (adjusted hazard ratio (aHR), (95% confidence interval (CI)), 2.80, [1.39-5.63]) and liver-related outcomes (3.70, [1.27-10.78]). Similar findings were observed for the association of baseline FIB-4 with mortality (2.49, [1.46-4.24]) and liver-related outcomes (11.50, [6.17-21.44]). In models considering designated time-point measurements of the scores, stronger associations were noted. For NFS, a higher time-point measurement was associated with a significantly higher risk of mortality (3.01, [1.65-5.49]) and liver-related outcomes (6.69, [2.62-17.06]). For FIB-4, higher time-point measurements were associated with significantly higher mortality (3.01, [1.88-4.82]) and liver-related outcomes (13.26, [6.89-25.53]). An annual increase in FIB-4 (2.70, [1.79-4.05]) or NFS (4.68, [1.52-14.44]) was associated with an increased risk of liver-related outcomes. No association between NFS/FIB-4 and risk of cardiovascular events was observed in both models.
CONCLUSIONS Higher aHRs describing the associations of FIB-4/NFS with overall mortality and liver-related outcomes were observed in the models that included designated time-point measurements of the scores. In addition to the baseline measurement, a routine monitoring on these scores may be important in predicting prognosis of NAFLD patients.
Copyright © 2024 Sung Won Chung et al.
Figures
그림 출처: PubMed Central 공개 논문 (PMC11419836)
Conflict of interest statement
The authors declare that they have no conflicts of interest.
그 밖의 정보
- 출판 형태
- Journal Article, Research Support, Non-U.S. Gov't
- 저널
- Canadian journal of gastroenterology & hepatology · eISSN 2291-2797
- 전자 출판
- 2024-09-16
- MeSH
- Humans · Non-alcoholic Fatty Liver Disease* / mortality / epidemiology · Male · Female · Republic of Korea / epidemiology · Middle Aged · Prognosis · Predictive Value of Tests* · Adult · Liver Cirrhosis / mortality · Severity of Illness Index · Proportional Hazards Models · Time Factors · Cohort Studies · Cardiovascular Diseases / mortality · Follow-Up Studies
- 참고문헌
- 41편